An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
SNV1521 in Participants with Advanced Solid Tumors
Trial Status: active
This study is testing a new medicine, SNV1521, for people with advanced cancers. The
researchers want to find out if SNV1521 is safe, well-tolerated, and effective in
treating solid tumors. They are investigating different doses in order to find the most
effective and safe one. They are also investigating whether it can be combined with other
cancer therapies.
Inclusion Criteria
Advanced or metastatic solid tumor malignancy
Evaluable or Measurable disease (RECIST 1.1 Criteria).
ECOG Performance Status 0 or 1.
Life expectancy > 3 months
Exclusion Criteria
History of other malignancy within the past 2 years
Prior diagnosis of Myelodysplastic syndrome or Acute Myeloid Leukemia
Significant cardiovascular disease within 6 months
Significant gastrointestinal disease
HIV infection with a CD4+ T-cell count < 200 cells/μL and/or a detectable viral load
Liver dysfunction
Additional locations may be listed on ClinicalTrials.gov for NCT06220864.
